UK digital pathology market was valued at $77.8 million in 2025 and is projected to reach $528.9 million by 2035, growing at a CAGR of 21.2% during the forecast period (2026–2035). The UK digital pathology market is being increasingly driven by the rising prevalence of cancer and chronic diseases. According to Macmillan Cancer Support, nearly 3.5 million individuals are currently living with cancer and more than 420,000 individuals are diagnosed with cancer each year in the UK, highlighting the growing demand for timely and accurate diagnostic services. Digital pathology offers enhanced capabilities for tissue analysis, biomarker quantification, and remote consultation, which can support faster and more consistent diagnoses. The increasing patient burden is driving healthcare providers to adopt technology-driven solutions that improve workflow efficiency and diagnostic accuracy. Additionally, the need for scalable and standardized pathology services in both oncology and chronic disease management is becoming more pronounced.
Browse the full report description of “UK Digital Pathology Market Size, Share & Trends Analysis Report by Product (Scanner Device, Software and Storage System), by Application (Teleconsultation, Disease Diagnosis and Drug Discovery and Other) and by End-User (Biotechnology & Pharmaceutical Companies, Hospitals and Others), Forecast Period, (2026-2035)” of https://www.omrglobal.com/industry-reports/uk-digital-pathology-market
Cancer Statistics in the UK Highlighting Diagnosis and Prevalence
Cancer continues to be the leading cause of mortality in the UK, with over 168,000 individuals succumbing to the disease annually, averaging approximately 460 per day. While the incidence of cancer has risen, mortality rates have increased at a considerably slower pace. Despite advances in treatment and early detection, performance against cancer waiting time targets across all UK nations declined to some of the lowest levels on record in 2023 and 2024. By 2025, a mixed picture emerged, with only partial improvements observed in meeting these targets. These trends underscore ongoing challenges in timely cancer diagnosis and treatment delivery within the UK healthcare system
Market Coverage
Key questions addressed by the report.
UK Digital Pathology Market Report Segment
By Product Type
By Application
By End-User
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/uk-digital-pathology-market